Gulf Pharmaceutical Industries
- 1.050 AED
- -0.010
- -0.94%
Gulf Pharmaceutical Industries Stock Overview
View Company ProfileStock Summary
| Last Price (AED) | 1.050 |
| Prev. Close | 1.060 |
| Day Range | 1.020 - 1.070 |
| 52WK range | |
| Turnover (M AED) | 0.259 |
| Volume (M) | 0.249 |
| Number of Trades | 68 |
| Market Cap (M AED) | 1,224.541 |
| Change in Market Cap (M AED) | |
| VWAP (AED) | 1.038 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M AED) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
Julphar generates higher net profits at AED 175m in...
Abu Dhabi - Mubasher: The net profits of Gulf Pharmaceutical Industries (Julphar) hit AED 175.30 million in 2025, reflecting higher year-on-year (YoY)...
Julphar turns into profitability in H1-25 backed by...
Abu Dhabi - Mubasher: Gulf Pharmaceutical Industries (Julphar) swung to profitability at AED 158.20 million in the first half (H1) of 2025, against net...
Julphar’s drives portfolio progress in MENA with 14%...
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) recorded sales valued at AED 1.30 billion in the first nine months (9M) of 2024,...
Julphar sees lower net losses in H1-24; revenues up...
Abu Dhabi – Mubasher: The net losses of Gulf Pharmaceutical Industries (Julphar) retreated to AED 2.40 million in the first half (H1)...
Julphar turns profitable in Q1-24; accumulated losses...
Abu Dhabi – Mubasher: Gulf Pharmaceutical Industries (Julphar) logged net profits attributable to the owners amounting to AED 1.90...
